
Weekly updatesJun 01, 2026
Weekly Market Outlook | May 25 - May 31, 2026
Edge Capital's weekly assessment of geopolitical risk, capital flows, protocol developments, and market structure across digital assets
Six venture rounds disclosed $80.2M; Binance's $100M Circle stake and MoonPay's $60M+ North Capital deal are under M&A
The CLARITY Act, the bill meant to set the rules for crypto, fell one vote short in the Senate on September 15. Within ten days two regulators filled the gap. The Federal Reserve published the rules stablecoin issuers under its watch will follow, and SEC staff answered the question every token project has been asking: does buying back your own token make it a security?
The Fed's proposal turns the GENIUS Act, the stablecoin law passed last year, into a checklist. For issuers supervised by the Fed, which means subsidiaries of state-chartered member banks, the rules are:
The cost lands hardest on small issuers, which favours scale and bank ownership. Comments are open for 60 days, and the law takes effect by January 18, 2027 at the latest.
The GENIUS Act bans issuers from paying interest to holders. The Fed's proposal closes the obvious workaround: if an issuer pays an exchange, wallet or white-label partner, and that partner then rewards customers for holding the coin, the Fed will presume the ban has been broken unless the issuer can show otherwise. Ordinary merchant discounts and profit-sharing with independent partners remain allowed. The clause describes deals signed this week: Circle agreed to pay Binance a monthly fee tied to USDC balances on its platform, and Binance Wallet started paying USDe holders up to 4.75%. Neither issuer is Fed-supervised today, but the rule sets the standard such programmes will be measured against.
In simple terms, the SEC staff said that a project which uses its revenue to buy back its own token, the way a company buys back shares, is not turning that token into a security, provided the network is already running. The reasoning is the Howey test, the legal test for a security, which asks whether buyers rely on a manager's efforts to make them money. The staff's answers:
This gives cover to the buyback programmes now common in DeFi, from Ethena's planned fee switch to Derive's 84-week programme. These are staff views with no legal force, not a rule.
Institutions now have workable guidance without waiting for Congress: the cost of issuing a stablecoin has a formula, and token buybacks have a green light. In our view that favours the largest issuers and exchange-owned distribution, because scale spreads the capital cost and partners can be paid within the rules. The risk is durability. Proposals can change after the comment period, the FDIC's April version sets capital differently, staff guidance can be withdrawn, and the SEC's most crypto-friendly commissioner leaves on October 2. Until Congress legislates, the rulebook is written in pencil.
USDe supply stood at $4.95B on September 28, against a peak of $14.8B on October 4, 2025 and a low of $3.88B on August 1. It has added about $1B since September 1, while ENA rose 64% over 30 days to $0.27. Staked supply has fallen faster: sUSDe holds $1.30B against $5.86B in October 2025, so fewer holders are collecting the yield. The recovery coincides with promotional rewards rather than a higher underlying rate.
Ethena's April overhaul cut the crypto funding trade, in which USDe holds ether or bitcoin and shorts the matching futures to collect the funding paid by leveraged traders, to 11% of backing and added lending and real-world assets. By early July, governance data cited by Crypto.news put that trade at roughly $39M, or 1% of backing, with DeFi lending at 46%, ordinary stablecoins at 35%, tokenised bonds and bills at 11.2% and loans to institutions at 6.9%, including a $1B credit line with FalconX. The trade was cut because its income collapsed: bitcoin funding paid 11.0% a year in 2024, 4.9% in 2025 and 2.2% in 2026 through August 11, on Ethena's data. Funding has since recovered to about 5.7% for BTC and 4.8% for ETH on Binance in September, but USDe is now a managed portfolio of loans and bonds with a yield set by lending markets.
On September 25 Ethena began running the same trade on stocks: it holds Binance's tokenised shares, bStocks, and shorts the matching Binance equity futures, collecting the funding without a view on the stock price. Binance has more than $2.9B of open interest in these contracts, but the return is unstable: Ethena quotes a 3.56% average over six months, while its risk adviser Kairos measured about 18% in late July and 7% by August 26, with two stocks paying negative. Only stocks with at least $25M of open interest over 14 days, 30 days of funding history and a matching token on the same venue qualify; 17 passed on Binance, three on OKX and none on Bybit or Kraken. Two risks stand out:
Spot, hedge and issuer all sit inside one company.
The leverage on USDe is concentrated on Morpho. Its API shows $784M borrowed against USDe collateral, led by USDe/USDC on Base ($351M at 4.13%) and USDe/USDG on Robinhood Chain ($303M at 4.06%), two of the three largest markets on the protocol, plus sUSDe/PYUSD on Ethereum ($92M at 4.06%). All three allow borrowing up to 91.5% of collateral value and run near 90% utilisation, so a borrower can lever roughly ten times and pays about 4.1% per turn. On Aave V3 Ethereum, USDC borrows at 4.41% and USDT at 5.03% against sUSDe paying 5.09%.
Most of that borrowing is looped: USDe posted as collateral, stablecoins borrowed and swapped back into USDe. Unstaked USDe pays nothing, so the return comes from a 5% reward paid through Merkl to USDe deposited on those markets. Net of the 4.1% borrow cost that is about one point per turn, or roughly 9% at maximum leverage, and every point of it is an incentive. The staked route is no better: sUSDe at 5.09% against a 4.41% USDC borrow on Aave leaves 0.7 points. Ethena has said the token incentives that funded USDe growth end this month. If the Merkl rewards follow, the loop stops paying.
ENA holders approved a plan on September 2 to spend 95% of Ethena's net revenue buying back ENA, but it only switches on once USDe supply reaches $7.5B, which needs another 52% of growth from today; Ethena's own illustration puts the first-year buyback at $22.5M. Before that, all remaining early-investor tokens unlock in a single release on October 5, estimated by Tokenomist at about 1.41B ENA, roughly 14% of circulating supply and $374M at current prices, while team and foundation tokens keep vesting monthly until 2028. ENA has risen 240% in 60 days on a buyback that does not yet exist. The October 5 release and the pace of USDe growth toward $7.5B will decide whether the re-rating holds.
Disclaimer
This communication is for information purposes only and is not an advertisement, an offer, invitation or a solicitation to buy or sell securities or investment products, an official confirmation of any kind and is not intended as investment advice or recommendation. Before making an investment decision, investors should ensure they have sufficient information to ascertain the legal, financial, tax and regulatory consequences of an investment to enable them to make an informed investment decision. The information in this communication is subject to change without notice. No warranty is made as to the completeness or accuracy of the information contained in this communication, and the information in this email may be erroneous, invalid and/or unsubstantiated. The sender therefore does not accept liability for any errors, omissions or adverse consequences in the contents of this message which arise as a result of e-mail transmission or for any other reason.
The performance and value of any financial product may fluctuate and may be subject to sudden and large movements that could result in a loss equal to or in excess of the amount invested. Past performance is not a guide to future performance, future returns are not guaranteed, and a loss of original capital may occur. The presented figures are based on estimates, assumptions, models and third-party data, any or all of which may prove to be inaccurate.